US$ 24.23
bpc-157 evidence human trials safety regulatory status clinical review BPC- 157 Research Peptide bpc-157 human clinical trials evidence
Description
doi: 10.1007/s40279-024-02130-0
Common signs include: Persistent fatigue or weakness Pale or slightly yellow skin Shortness of breath Tingling or numbness in the hands and feet Difficulty with memory or concentration In more advanced cases, neurological symptoms may become more pronounced
In animal models of stroke, BPC-157 was able to reduce brain damage and improve functional recovery [11,12]

[DOI] [PMC free article] [PubMed] [Google Scholar] 154.Schimmel P, Giege R, Moras D, Yokoyama S
